Cargando…
Clinical Efficacy and Safety of Sodium Thiosulfate in the Treatment of Uremic Pruritus: A Meta-Analysis of Randomized Controlled Trials
Uremic pruritus is a distressful complication of chronic kidney disease and results in impaired quality of life and higher mortality rates. Intravenous sodium thiosulfate has been reported to alleviate pruritus in hemodialysis patients. We performed a systematic review and meta-analysis to estimate...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8624535/ https://www.ncbi.nlm.nih.gov/pubmed/34822553 http://dx.doi.org/10.3390/toxins13110769 |
_version_ | 1784606197561688064 |
---|---|
author | Lu, Ping-Hsun Chuo, Hui-En Kuo, Ko-Lin Liao, Jian-Fu Lu, Po-Hsuan |
author_facet | Lu, Ping-Hsun Chuo, Hui-En Kuo, Ko-Lin Liao, Jian-Fu Lu, Po-Hsuan |
author_sort | Lu, Ping-Hsun |
collection | PubMed |
description | Uremic pruritus is a distressful complication of chronic kidney disease and results in impaired quality of life and higher mortality rates. Intravenous sodium thiosulfate has been reported to alleviate pruritus in hemodialysis patients. We performed a systematic review and meta-analysis to estimate the efficacy of intravenous sodium thiosulfate in patients with uremic pruritus. A systematic search of electronic databases up to June 2021 was conducted for randomized controlled trials that evaluated the clinical effects of sodium thiosulfate in the management of patients with uremic pruritus. Two reviewers selected eligible articles and evaluated the risk of bias; the results of pruritus assessment and uremic pruritus-related laboratory parameters in selected studies were analyzed. There are four trials published between 2018 and 2021, which include 222 participants. The sodium thiosulfate group displayed significant decrease in the pruritus score (standardized mean difference = −3.52, 95% confidence interval = −5.63 to −1.41, p = 0.001), without a significant increase in the adverse effects (risk ratio = 2.44, 95% confidence interval = 0.37 to 15.99, p = 0.35) compared to the control group. Administration of sodium thiosulfate is found to be a safe and efficacious complementary therapy in improving uremic pruritus in patients with chronic kidney disease. |
format | Online Article Text |
id | pubmed-8624535 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-86245352021-11-27 Clinical Efficacy and Safety of Sodium Thiosulfate in the Treatment of Uremic Pruritus: A Meta-Analysis of Randomized Controlled Trials Lu, Ping-Hsun Chuo, Hui-En Kuo, Ko-Lin Liao, Jian-Fu Lu, Po-Hsuan Toxins (Basel) Article Uremic pruritus is a distressful complication of chronic kidney disease and results in impaired quality of life and higher mortality rates. Intravenous sodium thiosulfate has been reported to alleviate pruritus in hemodialysis patients. We performed a systematic review and meta-analysis to estimate the efficacy of intravenous sodium thiosulfate in patients with uremic pruritus. A systematic search of electronic databases up to June 2021 was conducted for randomized controlled trials that evaluated the clinical effects of sodium thiosulfate in the management of patients with uremic pruritus. Two reviewers selected eligible articles and evaluated the risk of bias; the results of pruritus assessment and uremic pruritus-related laboratory parameters in selected studies were analyzed. There are four trials published between 2018 and 2021, which include 222 participants. The sodium thiosulfate group displayed significant decrease in the pruritus score (standardized mean difference = −3.52, 95% confidence interval = −5.63 to −1.41, p = 0.001), without a significant increase in the adverse effects (risk ratio = 2.44, 95% confidence interval = 0.37 to 15.99, p = 0.35) compared to the control group. Administration of sodium thiosulfate is found to be a safe and efficacious complementary therapy in improving uremic pruritus in patients with chronic kidney disease. MDPI 2021-10-30 /pmc/articles/PMC8624535/ /pubmed/34822553 http://dx.doi.org/10.3390/toxins13110769 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Lu, Ping-Hsun Chuo, Hui-En Kuo, Ko-Lin Liao, Jian-Fu Lu, Po-Hsuan Clinical Efficacy and Safety of Sodium Thiosulfate in the Treatment of Uremic Pruritus: A Meta-Analysis of Randomized Controlled Trials |
title | Clinical Efficacy and Safety of Sodium Thiosulfate in the Treatment of Uremic Pruritus: A Meta-Analysis of Randomized Controlled Trials |
title_full | Clinical Efficacy and Safety of Sodium Thiosulfate in the Treatment of Uremic Pruritus: A Meta-Analysis of Randomized Controlled Trials |
title_fullStr | Clinical Efficacy and Safety of Sodium Thiosulfate in the Treatment of Uremic Pruritus: A Meta-Analysis of Randomized Controlled Trials |
title_full_unstemmed | Clinical Efficacy and Safety of Sodium Thiosulfate in the Treatment of Uremic Pruritus: A Meta-Analysis of Randomized Controlled Trials |
title_short | Clinical Efficacy and Safety of Sodium Thiosulfate in the Treatment of Uremic Pruritus: A Meta-Analysis of Randomized Controlled Trials |
title_sort | clinical efficacy and safety of sodium thiosulfate in the treatment of uremic pruritus: a meta-analysis of randomized controlled trials |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8624535/ https://www.ncbi.nlm.nih.gov/pubmed/34822553 http://dx.doi.org/10.3390/toxins13110769 |
work_keys_str_mv | AT lupinghsun clinicalefficacyandsafetyofsodiumthiosulfateinthetreatmentofuremicpruritusametaanalysisofrandomizedcontrolledtrials AT chuohuien clinicalefficacyandsafetyofsodiumthiosulfateinthetreatmentofuremicpruritusametaanalysisofrandomizedcontrolledtrials AT kuokolin clinicalefficacyandsafetyofsodiumthiosulfateinthetreatmentofuremicpruritusametaanalysisofrandomizedcontrolledtrials AT liaojianfu clinicalefficacyandsafetyofsodiumthiosulfateinthetreatmentofuremicpruritusametaanalysisofrandomizedcontrolledtrials AT lupohsuan clinicalefficacyandsafetyofsodiumthiosulfateinthetreatmentofuremicpruritusametaanalysisofrandomizedcontrolledtrials |